News on immunoassay systems and applications.
A recent study highlights the ability of the company's prognostic tool to detect levels of circulating tumor cells in angiosarcoma patients.
The test is a lateral flow, in vitro qualitative immunoassay that detects human antibodies to HIV virus type 1 and type 2 in whole blood.
The quantitative immunoassay measures the concentration of a novel antibiotic, plazomicin (Zemdri), using the automated clinical chemistry analyzer Beckman Coulter AU 680.
The Massachusetts Institute of Technology spinout has created a new class of activity sensors that query the body and report back clinically relevant information.
A court in San Diego has stated that part of the suit between Quidel and Beckman is void as a matter of law.
